Biotech ExpreS2ion Biotechnologies - that develops vaccines for covid-19, breast cancer, influenza and malaria - is currently conducting a rights issue of
Watch the interview at biostock.se:
https://www.biostock.se/en/2022/04/biostock-studio-expres2ions-ceo-gives-status-update/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
https://news.cision.com/expres2ion-biotechnologies/r/biostock-studio--expres2ion-s-ceo-gives-status-update,c3549897
(c) 2022 Cision. All rights reserved., source